Concepedia

M. Riofrio

MR

6

Publications

890

Citations

6

H-Index

2001

Active since

Affiliations

Hôpital René Huguenin(Current)

Institut Gustave Roussy

Hôpital Paul-Brousse

M. Riofrio is an author at Hôpital René Huguenin specializing in cancer therapeutics, cancer research, and tumor biology.

Top concepts

Publications per year

2001–2006

6

Publications

6

Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients

Alejandro Yovine, M. Riofrio, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2004 · 309 citations

Ecteinascidin-743: A Marine-Derived Compound in Advanced, Pretreated Sarcoma Patients—Preliminary Evidence of Activity

Suzette Delaloge, Alejandro Yovine, A. Taamma et al. · Journal of Clinical Oncology · 2001 · 167 citations

Phase I and Pharmacokinetic Study of Ecteinascidin-743, a New Marine Compound, Administered as a 24-hour Continuous Infusion in Patients With Solid Tumors

A. Taamma, J. L. Misset, M. Riofrio et al. · Journal of Clinical Oncology · 2001 · 160 citations

Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma

Laurent Zelek, S. Barthier, M. Riofrio et al. · Cancer · 2001 · 157 citations · Full text

A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer

Laurent Zelek, Alejandro Yovine, Étienne Brain et al. · British Journal of Cancer · 2006 · 86 citations · Full text

Rows per page

1–5 of 6